Bionexus Gene Lab approved the appointment of Chi Yuen Leong as the Chief Executive Officer and a director, effective October 12. Leong has no family relationship with any director or executive officer of the company. He was not involved in any transaction with the company during the past two years. Leong served as the president and director from the company’s inception to August 2022 and has been working with and guiding Bionexus Gene Lab’s listing on OTC and Nasdaq. Leong entered into an employment agreement with the company dated October 12 and agreed to receive an annual compensation of $24,000.
Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>